Theresa Hegmann. Show Affiliations »
Abstract
Mesh： See more » CelecoxibCyclooxygenase Inhibitors/adverse effectsCyclooxygenase Inhibitors/therapeutic useHumansLactones/adverse effectsLactones/therapeutic useOsteoarthritis/drug therapyProduct Surveillance, PostmarketingPyrazoles/adverse effectsPyrazoles/therapeutic useSulfonamides/adverse effectsSulfonamides/therapeutic useSulfones/adverse effectsSulfones/therapeutic useUnited StatesUnited States Food and Drug Administration
Substances： See more » Cyclooxygenase InhibitorsLactonesPyrazolesSulfonamidesSulfonesrofecoxibCelecoxib
Year: 2005 PMID： 15789666 DOI： 10.1097/01720610-200503000-00004
Source DB: PubMed Journal: JAAPA ISSN： 0893-7400